Upfront low‐dose ponatinib (15 mg/day) for multi‐TKI resistant chronic myeloid leukemia

Saved in:
Bibliographic Details
Published in:Hematological oncology 2018-10, Vol.36 (4), p.718-720
Main Author: Tefferi, Ayalew
Format: Article
Language:English
Subjects:
Chronic myeloid leukemia
Leukemia
Myeloid leukemia
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0278-0232
1099-1069
DOI:10.1002/hon.2517